In a recent interview with PharmaShots, Dr. Spetzler, President and Chief Scientific Officer of Caris Life Sciences shared his insights on FOLFOXai and its importance in patients with metastatic colorectal cancer. He also highlights the data supporting the use of FOLFOXai as a predictor of CT efficacy in patients with mCRC.
Shots:
The validation studies of MI…
